Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $59 | 5 days |
Description | Forodesine (BCX-1777) is an orally active and potent purine nucleoside phosphorylase (PNP) inhibitor, a new purine nucleoside analog, inhibitor of human lymphocyte proliferation, induces apoptosis in leukemic cells by increasing dGTP levels, and may be useful in the study of cutaneous T-cell lymphomas. |
In vitro | Formodicin (10-30 μM; 24 and 48 hours; RPMI-8226, MOLT-4 and 5T33MM cells) has no effect on MM cells at 24 hours, but decreases the percentage of viable cells in MOLT-4 cells by 40% [1]. Treatment with forodosine (10-30 μM; 24 and 48 h; RPMI-8226, MOLT-4 and 5T33MM cells) partially inhibited cell proliferation [1]. In the presence of 2'-deoxyguanosine (dGuo, 3-10 μM), fordifloxacin inhibits the proliferation of human lymphocytes activated by a variety of drugs such as interleukin-2 (IL-2), mixed lymphocyte reaction (MLR) and phytohemagglutinin (PHA) (IC50 values less than 0.1-0.38 μM) [2]. |
In vivo | Forodesine has excellent oral bioavailability (63%) in mice[2]. Forodesine(single dose of 10 mg/kg; in mice ) treatment, elevates dGuo to approximately 5 μM[2]. Forodesine is effective in prolonging the life span 2-fold or more, in the human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL-SCID) mouse model[2]. |
Alias | Immucillin-H, BCX-1777 |
Molecular Weight | 266.25 |
Formula | C11H14N4O4 |
Cas No. | 209799-67-7 |
Storage | store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (300.47 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.